Augmedix, Inc. (NASDAQ:AUGX) Short Interest Down 18.9% in September

Augmedix, Inc. (NASDAQ:AUGX - Get Free Report) was the recipient of a large decline in short interest during the month of September. As of September 15th, there was short interest totalling 1,070,000 shares, a decline of 18.9% from the August 31st total of 1,320,000 shares. Based on an average daily trading volume, of 822,500 shares, the short-interest ratio is presently 1.3 days. Approximately 2.2% of the company's stock are sold short.

Institutional Trading of Augmedix

A number of institutional investors have recently bought and sold shares of the business. Ghisallo Capital Management LLC acquired a new position in shares of Augmedix in the 4th quarter valued at approximately $146,000. Symmetry Peak Management LLC acquired a new position in shares of Augmedix in the 4th quarter valued at approximately $88,000. Parkman Healthcare Partners LLC raised its position in shares of Augmedix by 170.1% in the 4th quarter. Parkman Healthcare Partners LLC now owns 1,015,814 shares of the company's stock valued at $5,943,000 after buying an additional 639,732 shares in the last quarter. Norden Group LLC raised its position in shares of Augmedix by 50.2% in the 1st quarter. Norden Group LLC now owns 19,152 shares of the company's stock valued at $78,000 after buying an additional 6,401 shares in the last quarter. Finally, Essex Investment Management Co. LLC raised its position in shares of Augmedix by 31.1% in the 1st quarter. Essex Investment Management Co. LLC now owns 528,985 shares of the company's stock valued at $2,164,000 after buying an additional 125,457 shares in the last quarter. Institutional investors own 87.11% of the company's stock.

Augmedix Stock Performance

NASDAQ AUGX traded up $0.01 during trading on Friday, reaching $2.34. The company's stock had a trading volume of 96,859 shares, compared to its average volume of 642,226. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 1.48. The firm has a market capitalization of $114.59 million, a price-to-earnings ratio of -5.44 and a beta of -0.22. Augmedix has a 12 month low of $0.73 and a 12 month high of $6.25. The firm has a 50 day moving average price of $2.29 and a 200 day moving average price of $2.19.

Augmedix (NASDAQ:AUGX - Get Free Report) last posted its quarterly earnings data on Monday, August 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by ($0.04). The business had revenue of $13.66 million during the quarter, compared to the consensus estimate of $13.68 million. Augmedix had a negative net margin of 46.23% and a negative return on equity of 182.36%. As a group, equities analysts anticipate that Augmedix will post -0.45 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on AUGX shares. Lake Street Capital reissued a "hold" rating on shares of Augmedix in a research report on Monday, July 22nd. William Blair downgraded shares of Augmedix from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 19th. Finally, B. Riley downgraded shares of Augmedix from a "strong-buy" rating to a "hold" rating and reduced their target price for the stock from $3.00 to $2.35 in a report on Friday, July 19th. Four research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $3.09.

Augmedix Company Profile

Augmedix, Inc provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits.